| Literature DB >> 28968778 |
Igor Bazov1, Daniil Sarkisyan1, Olga Kononenko1, Hiroyuki Watanabe1, Mumtaz Malik Taqi1,2, Lada Stålhandske1, Dineke S Verbeek3, Jan Mulder4, Grazyna Rajkowska5, Donna Sheedy6, Jillian Kril6, Xueguang Sun7,8, Ann-Christine Syvänen9, Tatiana Yakovleva1, Georgy Bakalkin1.
Abstract
Molecular mechanisms that define patterns of neuropeptide expression are essential for the formation and rewiring of neural circuits. The prodynorphin gene (PDYN) gives rise to dynorphin opioid peptides mediating depression and substance dependence. We here demonstrated that PDYN is expressed in neurons in human dorsolateral prefrontal cortex (dlPFC), and identified neuronal differentially methylated region in PDYN locus framed by CCCTC-binding factor binding sites. A short, nucleosome size human-specific promoter CpG island (CGI), a core of this region may serve as a regulatory module, which is hypomethylated in neurons, enriched in 5-hydroxymethylcytosine, and targeted by USF2, a methylation-sensitive E-box transcription factor (TF). USF2 activates PDYN transcription in model systems, and binds to nonmethylated CGI in dlPFC. USF2 and PDYN expression is correlated, and USF2 and PDYN proteins are co-localized in dlPFC. Segregation of activatory TF and repressive CGI methylation may ensure contrasting PDYN expression in neurons and glia in human brain.Entities:
Mesh:
Substances:
Year: 2018 PMID: 28968778 PMCID: PMC6887740 DOI: 10.1093/cercor/bhx181
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357